Lung cancer is the #1 cancer
killer worldwide.

But what if it was easy to detect?

The OncoSwab Advantage

Non-Invasive

OncoSwab tests nasal fluids to eliminate the discomfort and risk associated with more invasive procedures.

Ease of Use

Compatible with self-testing and point-of-care sites, eliminating the need for specialized medical personnel.

Risk Assessment

Faster and more accessible testing for higher-risk individuals, especially targeting those with incidental pulmonary nodules.

Cost Effective

Designed to reduce unnecessary invasive procedures, our test offers earlier, more accurate assessments of lung nodules, leading to significant cost savings compared to traditional methods.

The Science

Assessing lung nodules often involves costly procedures and invasive biopsies, with a significant chance of inconclusive results. Our patent-pending technology offers a more accessible and precise way to assess nodule malignancy risk, helping clinicians make informed decisions sooner and reducing the need for invasive follow-ups.

About OncoSwab

It all started with a crazy idea at a hackathon. Two young scientists, Andrea Stephany and Pablo Lara, decided to leave everything behind to bring their vision to reality: a nasal swab to simplify lung cancer detection, accessible from anywhere

Read More

Early Detection Saves Lives!

2,206,759
Confirmed Cases 2020
1,796,133
Worldwide Deaths 2020
3,799,989
Projected Cases 2050
3,199,989
Projected Deaths by 2050